Cartesian Therapeutics, Inc. Common Stock

$5.82
-0.73 (-11.15%)

Volume:

269.49K ($1.57M)

Market Capitalization:

$171.00M

Cartesian Therapeutics Price Chart

Cartesian Therapeutics Price Chart11:58 AM1:18 PM2:38 PM3:58 PM5:18 PM6:38 PM7:58 PM6.096.045.995.935.885.835.78

Cartesian Therapeutics Volume Chart

Cartesian Therapeutics Volume Chart11:58 AM1:18 PM2:38 PM3:58 PM5:18 PM6:38 PM7:58 PM14.94K12.80K10.67K8.54K6.40K4.27K2.13K

Cartesian Therapeutics Market Segments

After Hours

-0.02(-0.34%)
Open$5.84
Close$5.82
Low$5.82
Low Change-0.02 (-0.34%)
High$5.84
High Change+0.00 (+0.00%)
Range$0.02
Volume12.27K
Dollar Volume$71.41K

Regular Trading Hours

-0.71(-10.81%)
Open$6.52
Close$5.82
Low$5.77
Low Change-0.75 (-11.50%)
High$6.71
High Change+0.19 (+2.85%)
Range$0.94
Volume257.22K
Dollar Volume$1.50M

Premarket

*No Trades in Segment

After Hours Yesterday

+0.00(+0.00%)
Open$6.55
Close$6.55
Low$6.55
Low Change0.00 (0.00%)
High$6.55
High Change+0.00 (+0.00%)
Range$0.00
Volume4.799K
Dollar Volume$31.43K

Regular Trading Hours Yesterday

+0.23(+3.64%)
Open$6.32
Close$6.55
Low$6.32
Low Change0.00 (0.00%)
High$6.97
High Change+0.65 (+10.28%)
Range$0.65
Volume72.962K
Dollar Volume$477.90K

Premarket Yesterday

*No Trades in Segment

Cartesian Therapeutics Moving Averages

5 Day Moving Average (SMA5)$6.75
10 Day Moving Average (SMA10)$6.78
20 Day Moving Average (SMA20)$7.27
50 Day Moving Average (SMA50)$6.82
100 Day Moving Average (SMA100)$7.00
200 Day Moving Average (SMA200)$7.84

Cartesian Therapeutics Statistics

Average Volume (30 Days)172.27K
P/E Ratio (Current)-1.19
EPS (Current)-$5.26
Dividend Yield0.00%
Free Cash Flow-$77.37M
Cash Ratio7.44
Current Ratio7.65
Quick Ratio7.65
Debt to Equity0.00
Enterprise Value$65.58M
EV to EBITDA-0.74
EV to Sales36.95
Price to Book-1.24
Price to Cash Flow
Price to Free Cash Flow
Price to Sales103.79
Return on Assets-0.54%
Return on Equity1.04%

Cartesian Therapeutics Stock Splits

There have been 2 stock splits for Cartesian Therapeutics (RNAC). The last reverse stock split occured on April 5, 2024 and reduced the outstanding shares at a ratio of 30:1.

DateTypeRatio
Apr 5, 2024Reverse30:1
Dec 1, 2023Forward1:2

Cartesian Therapeutics Dividends

There have been no dividends for Cartesian Therapeutics (RNAC).